ENTITY: - **Bayer**
DATE: 13-03-2026

**Forensic Audit Memo – Bayer AG**

**Objective:** Conduct a forensic review of Bayer’s financial records and compliance documentation to identify potential fraud, misreporting, or regulatory non-compliance within its pharmaceutical and chemical divisions.

**Scope:** Examine transactional data, vendor relationships, clinical trial disclosures, and patent licensing agreements for anomalies, focusing on high-risk areas such as R&D cost allocations and marketing expenditures.

**Methodology:** Employ data analytics, document sampling, and interviews with key personnel to detect irregularities, supported by forensic accounting tools and regulatory benchmarking.

**Deliverable:** A detailed report outlining findings, risk assessments, and remediation recommendations to ensure adherence to GAAP, IFRS, and industry-specific regulations.

**Confidentiality:** Strictly maintained per internal audit protocols.

—
*Prepared by [Your Name/Team], [Date]*

[NOTARIZED BY 2A AGENCY]